三五互聯(300051.SZ):實控人龔少暉所持股份部分被司法(再)凍結
格隆匯 1 月 29日丨三五互聯(300051.SZ)公佈,公司近日通過中國證券登記結算有限責任公司系統查詢並取得公司控股股東、實際控制人龔少暉的吿知函,獲悉龔少暉所持股份部分被司法(再)凍結;現將相關情況公吿如下:

控股股東、實際控制人累計被凍結股份數量(含本次及司法再凍結)佔其所持公司股份數量的57.99%,累計進入強制執行程序(含處於債務核實階段可能強制執行)的股份數量佔其所持公司股份的75.06%;請投資者注意相關風險。
控股股東、實際控制人所持公司股份存在被平倉或被強制過户的可能;請投資者注意相關風險
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.